Title : A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer.

Pub. Date : 2022 Jul

PMID : 35526308






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Recent preclinical data suggest that regorafenib may enhance the antitumor activity of anti-PD-1 immunotherapy. regorafenib programmed cell death 1 Homo sapiens